AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
SUPPRESSION OF HUMAN PROSTATE CARCINOMA METASTASES IN SEVERE COMBINEDIMMUNODEFICIENT MICE BY INTERLEUKIN-2 IMMUNOCYTOKINE THERAPY
Authors: DOLMAN CS MUELLER BM LODE HN XIANG R GILLIES SD REISFELD RA
Citation: Cs. Dolman et al., SUPPRESSION OF HUMAN PROSTATE CARCINOMA METASTASES IN SEVERE COMBINEDIMMUNODEFICIENT MICE BY INTERLEUKIN-2 IMMUNOCYTOKINE THERAPY, Clinical cancer research, 4(10), 1998, pp. 2551-2557
CONSTRUCTION OF PHOSPHORYLATABLE CHIMERIC MONOCLONAL-ANTIBODY CC49 WITH A TYROSINE SRC KINASE RECOGNITION SITE
Authors: LIN L GILLIES SD SCHLOM J PESTKA S
Citation: L. Lin et al., CONSTRUCTION OF PHOSPHORYLATABLE CHIMERIC MONOCLONAL-ANTIBODY CC49 WITH A TYROSINE SRC KINASE RECOGNITION SITE, International journal of oncology, 13(4), 1998, pp. 725-732
CONSTRUCTION OF PHOSPHORYLATABLE CHIMERIC MONOCLONAL-ANTIBODY CC49
Authors: LIN L GILLIES SD LAN Y IZOTOVA L WU W SCHLOM J PESTKA S
Citation: L. Lin et al., CONSTRUCTION OF PHOSPHORYLATABLE CHIMERIC MONOCLONAL-ANTIBODY CC49, International journal of oncology, 13(1), 1998, pp. 115-120
PHASE-I TRIAL OF A HUMAN-MOUSE CHIMERIC ANTI-DISIALOGANGLIOSIDE MONOCLONAL-ANTIBODY CH14.18 IN PATIENTS WITH REFRACTORY NEUROBLASTOMA AND OSTEOSARCOMA
Authors: YU AL UTTENREUTHERFISCHER MM HUANG CS TSUI CC GILLIES SD REISFELD RA KUNG FH
Citation: Al. Yu et al., PHASE-I TRIAL OF A HUMAN-MOUSE CHIMERIC ANTI-DISIALOGANGLIOSIDE MONOCLONAL-ANTIBODY CH14.18 IN PATIENTS WITH REFRACTORY NEUROBLASTOMA AND OSTEOSARCOMA, Journal of clinical oncology, 16(6), 1998, pp. 2169-2180
HIGH-LEVEL EXPRESSION AND SECRETION OF FC-X FUSION PROTEINS IN MAMMALIAN-CELLS
Authors: LO KM SUDO Y CHEN J LI Y LAN Y KONG SM CHEN LL AN Q GILLIES SD
Citation: Km. Lo et al., HIGH-LEVEL EXPRESSION AND SECRETION OF FC-X FUSION PROTEINS IN MAMMALIAN-CELLS, Protein engineering (Print), 11(6), 1998, pp. 495-500
IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY
Authors: LODE HN XIANG R BECKER JC GILLIES SD REISFELD RA
Citation: Hn. Lode et al., IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY, Pharmacology & therapeutics (Oxford), 80(3), 1998, pp. 277-292
ANTIBODY-IL-12 FUSION PROTEINS ARE EFFECTIVE IN SCID MOUSE MODELS OF PROSTATE AND COLON-CARCINOMA METASTASES
Authors: GILLIES SD LAN Y WESOLOWSKI JS QIAN XQ REISFELD RA HOLDEN S SUPER M LO KM
Citation: Sd. Gillies et al., ANTIBODY-IL-12 FUSION PROTEINS ARE EFFECTIVE IN SCID MOUSE MODELS OF PROSTATE AND COLON-CARCINOMA METASTASES, The Journal of immunology, 160(12), 1998, pp. 6195-6203
INDUCTION OF PERSISTENT TUMOR-PROTECTIVE IMMUNITY IN MICE CURED OF ESTABLISHED COLON-CARCINOMA METASTASES
Authors: XIANG R LODE HN DREIER T GILLIES SD REISFELD RA
Citation: R. Xiang et al., INDUCTION OF PERSISTENT TUMOR-PROTECTIVE IMMUNITY IN MICE CURED OF ESTABLISHED COLON-CARCINOMA METASTASES, Cancer research, 58(17), 1998, pp. 3918-3925
NATURAL-KILLER CELL-MEDIATED ERADICATION OF NEUROBLASTOMA METASTASES TO BONE-MARROW BY TARGETED INTERLEUKIN-2 THERAPY
Authors: LODE HN XIANG R DREIER T VARKI NM GILLIES SD REISFELD RA
Citation: Hn. Lode et al., NATURAL-KILLER CELL-MEDIATED ERADICATION OF NEUROBLASTOMA METASTASES TO BONE-MARROW BY TARGETED INTERLEUKIN-2 THERAPY, Blood, 91(5), 1998, pp. 1706-1715
TARGETED INTERLEUKIN-2 THERAPY FOR SPONTANEOUS NEUROBLASTOMA METASTASES TO BONE-MARROW
Authors: LODE HN XIANG R VARKI NM DOLMAN CS GILLIES SD REISFELD RA
Citation: Hn. Lode et al., TARGETED INTERLEUKIN-2 THERAPY FOR SPONTANEOUS NEUROBLASTOMA METASTASES TO BONE-MARROW, Journal of the National Cancer Institute, 89(21), 1997, pp. 1586-1594
IMMUNOCYTOKINES - A NEW APPROACH TO IMMUNOTHERAPY OF MELANOMA
Authors: REISFELD RA BECKER JC GILLIES SD
Citation: Ra. Reisfeld et al., IMMUNOCYTOKINES - A NEW APPROACH TO IMMUNOTHERAPY OF MELANOMA, Melanoma research, 7, 1997, pp. 99-106
TARGETED CYTOKINE DELIVERY WITH RECOMBINANT ANTIBODY FUSION PROTEINS FOR THERAPEUTIC INTERVENTION
Authors: LODE HN XIANG R DREIER T GILLIES SD REISFELD RA
Citation: Hn. Lode et al., TARGETED CYTOKINE DELIVERY WITH RECOMBINANT ANTIBODY FUSION PROTEINS FOR THERAPEUTIC INTERVENTION, European journal of cancer, 33, 1997, pp. 302-302
ELIMINATION OF ESTABLISHED MURINE COLON-CARCINOMA METASTASES BY ANTIBODY-INTERLEUKIN-2 FUSION PROTEIN THERAPY
Authors: XIANG R LODE HN DOLMAN CS DREIER T VARKI NM QIAN XQ LO KM LAN Y SUPER M GILLIES SD REISFELD RA
Citation: R. Xiang et al., ELIMINATION OF ESTABLISHED MURINE COLON-CARCINOMA METASTASES BY ANTIBODY-INTERLEUKIN-2 FUSION PROTEIN THERAPY, Cancer research, 57(21), 1997, pp. 4948-4955
NK-CELL MEDIATED ERADICATION OF NEUROBLASTOMA METASTASES TO BONE-MARROW BY TARGETED INTERLEUKIN-2 THERAPY
Authors: LODE HN XIANG R DREIER T GILLIES SD REISFELD RA
Citation: Hn. Lode et al., NK-CELL MEDIATED ERADICATION OF NEUROBLASTOMA METASTASES TO BONE-MARROW BY TARGETED INTERLEUKIN-2 THERAPY, Blood, 90(10), 1997, pp. 1229-1229
ACTIVATION OF HUMAN EFFECTOR-CELLS BY A TUMOR REACTIVE RECOMBINANT ANTIGANGLIOSIDE GD(2) INTERLEUKIN-2 FUSION PROTEIN (CH14.18-IL2)
Authors: HANK JA SURFUS JE GAN JC JAEGER P GILLIES SD REISFELD RA SONDEL PM
Citation: Ja. Hank et al., ACTIVATION OF HUMAN EFFECTOR-CELLS BY A TUMOR REACTIVE RECOMBINANT ANTIGANGLIOSIDE GD(2) INTERLEUKIN-2 FUSION PROTEIN (CH14.18-IL2), Clinical cancer research, 2(12), 1996, pp. 1951-1959
ANTIBODY-INTERLEUKIN-2 FUSION PROTEINS - A NEW APPROACH TO CANCER-THERAPY
Authors: REISFELD RA GILLIES SD
Citation: Ra. Reisfeld et Sd. Gillies, ANTIBODY-INTERLEUKIN-2 FUSION PROTEINS - A NEW APPROACH TO CANCER-THERAPY, Journal of clinical laboratory analysis, 10(3), 1996, pp. 160-166
ERADICATION OF ESTABLISHED HEPATIC HUMAN NEUROBLASTOMA METASTASES IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY BY ANTIBODY-TARGETED INTERLEUKIN-2
Authors: PANCOOK JD BECKER JC GILLIES SD REISFEID RA
Citation: Jd. Pancook et al., ERADICATION OF ESTABLISHED HEPATIC HUMAN NEUROBLASTOMA METASTASES IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY BY ANTIBODY-TARGETED INTERLEUKIN-2, Cancer immunology and immunotherapy, 42(2), 1996, pp. 88-92
ERADICATION OF HUMAN HEPATIC AND PULMONARY MELANOMA METASTASES IN SCID MICE BY ANTIBODY-INTERLEUKIN-2 FUSION PROTEINS
Authors: BECKER JC PANCOOK JD GILLIES SD MENDELSOHN J REISFELD RA
Citation: Jc. Becker et al., ERADICATION OF HUMAN HEPATIC AND PULMONARY MELANOMA METASTASES IN SCID MICE BY ANTIBODY-INTERLEUKIN-2 FUSION PROTEINS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(7), 1996, pp. 2702-2707
AN ANTIBODY-INTERLEUKIN-2 FUSION PROTEIN OVERCOMES TUMOR HETEROGENEITY BY INDUCTION OF A CELLULAR IMMUNE-RESPONSE
Authors: BECKER JC VARKI N GILLIES SD FURUKAWA K REISFELD RA
Citation: Jc. Becker et al., AN ANTIBODY-INTERLEUKIN-2 FUSION PROTEIN OVERCOMES TUMOR HETEROGENEITY BY INDUCTION OF A CELLULAR IMMUNE-RESPONSE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(15), 1996, pp. 7826-7831
CHARACTERIZATION OF AN IG V-H IDIOTOPE THAT RESULTS IN SPECIFIC HOMOPHILIC BINDING AND INCREASED AVIDITY FOR ANTIGEN
Authors: YAN XY EVANS SV KAMINKI MJ GILLIES SD REISFELD RA HOUGHTON AN CHAPMAN PB
Citation: Xy. Yan et al., CHARACTERIZATION OF AN IG V-H IDIOTOPE THAT RESULTS IN SPECIFIC HOMOPHILIC BINDING AND INCREASED AVIDITY FOR ANTIGEN, The Journal of immunology, 157(4), 1996, pp. 1582-1588
T-CELL-MEDIATED ERADICATION OF MURINE METASTATIC MELANOMA INDUCED BY TARGETED INTERLEUKIN-2 THERAPY
Authors: BECKER JC PANCOOK JD GILLIES SD FURUKAWA K REISFELD RA
Citation: Jc. Becker et al., T-CELL-MEDIATED ERADICATION OF MURINE METASTATIC MELANOMA INDUCED BY TARGETED INTERLEUKIN-2 THERAPY, The Journal of experimental medicine, 183(5), 1996, pp. 2361-2366
LONG-LIVED AND TRANSFERABLE TUMOR-IMMUNITY IN MICE AFTER TARGETED INTERLEUKIN-2 THERAPY
Authors: BECKER JC VARKI N GILLIES SD FURUKAWA K REISFELD RA
Citation: Jc. Becker et al., LONG-LIVED AND TRANSFERABLE TUMOR-IMMUNITY IN MICE AFTER TARGETED INTERLEUKIN-2 THERAPY, The Journal of clinical investigation, 98(12), 1996, pp. 2801-2804
INVOLVEMENT OF B-LYMPHOCYTES IN THE GROWTH-INHIBITION OF HUMAN PULMONARY MELANOMA METASTASES IN ATHYMIC NU NU MICE BY IN ANTIBODY-LYMPHOTOXIN FUSION PROTEIN/
Authors: REISFELD RA GILLIES SD MENDELSOHN J VARKI NM BECKER JC
Citation: Ra. Reisfeld et al., INVOLVEMENT OF B-LYMPHOCYTES IN THE GROWTH-INHIBITION OF HUMAN PULMONARY MELANOMA METASTASES IN ATHYMIC NU NU MICE BY IN ANTIBODY-LYMPHOTOXIN FUSION PROTEIN/, Cancer research, 56(8), 1996, pp. 1707-1712
A PHASE-I STUDY OF HUMAN MOUSE CHIMERIC ANTIGANGLIOSIDE GD2 ANTIBODY CH14.18 IN PATIENTS WITH NEUROBLASTOMA
Authors: HANDGRETINGER R ANDERSON K LANG P DOPFER R KLINGEBIEL T SCHRAPPE M REULAND P GILLIES SD REISFELD RA NIETHAMMER D
Citation: R. Handgretinger et al., A PHASE-I STUDY OF HUMAN MOUSE CHIMERIC ANTIGANGLIOSIDE GD2 ANTIBODY CH14.18 IN PATIENTS WITH NEUROBLASTOMA, European journal of cancer, 31A(2), 1995, pp. 261-267
MAPPING EFFECTOR FUNCTIONS OF A MONOCLONAL-ANTIBODY TO GD3 BY CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTIBODY
Authors: CHAPMAN PB GILLIES SD HOUGHTON AN REILLY RM
Citation: Pb. Chapman et al., MAPPING EFFECTOR FUNCTIONS OF A MONOCLONAL-ANTIBODY TO GD3 BY CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTIBODY, Cancer immunology and immunotherapy, 39(3), 1994, pp. 198-204
Risultati: 1-25 | 26-30